1. Bakheet SA, Alzahrani MZ, Ansari MA, Nadeem A, Zoheir KM, Attia SM, Al-Ayadhi LY, Fayaz Ahmad S. {{Resveratrol Ameliorates Dysregulation of Th1, Th2, Th17, and T Regulatory Cell-Related Transcription Factor Signaling in a BTBR T + tf/J Mouse Model of Autism}}. {Mol Neurobiol};2016 (Aug 30)
Autism spectrum disorder (ASD) is a neurodevelopmental disorder. It is characterized by impaired social communication, abnormal social interactions, and repetitive behaviors and/or restricted interests. BTBR T + tf/J (BTBR) inbred mice are commonly used as a model for ASD. Resveratrol is used widely as a beneficial therapeutic in the treatment of an extensive array of pathologies, including neurodegenerative diseases. In the present study, the effect of resveratrol administration (20 and 40 mg/kg) was evaluated in both BTBR and C57BL/6 (B6) mice. Behavioral (self-grooming), Foxp3, T-bet, GATA-3, RORgammat, and IL-17A in CD4+ T cells were assessed. Our study showed that BTBR control mice exhibited a distinct immune profile from that of the B6 control mice. BTBR mice were characterized by lower levels of Foxp3+ and higher levels of RORgammat+, T-bet+, and GATA-3+ production in CD4+ T cells when compared with B6 control. Resveratrol (20 and 40 mg/kg) treatment to B6 and BTBR mice showed substantial induction of Foxp3+ and reduction of T-bet+, GATA-3+, and IL-17A+ expression in CD4+ cells when compared with the respective control groups. Moreover, resveratrol treatment resulted in upregulated expression of Foxp3 mRNA and decreased expression levels of T-bet, GATA-3, RORgammat, and IL-17A in the spleen and brain tissues. Western blot analysis confirmed that resveratrol treatment decreased the protein expression of T-bet, GATA-3, RORgamma, and IL-17 and that it increased Foxp3 in B6 and BTBR mice. Our results suggest that autism is associated with dysregulation of transcription factor signaling that can be corrected by resveratrol treatment.
Lien vers le texte intégral (Open Access ou abonnement)
2. Berard A, Boukhris T, Sheehy O. {{SSRI and autism: Additional data on the Quebec Pregnancy/Birth Cohort}}. {Am J Obstet Gynecol};2016 (Aug 30)
Lien vers le texte intégral (Open Access ou abonnement)
3. Cashin A, Yorke J. {{Overly Regulated Thinking and Autism Revisited}}. {J Child Adolesc Psychiatr Nurs};2016 (Aug 29)
PROBLEM: Humans exist within a socially mediated dynamical system. Frequent demands are experienced to respond to change in the environment to adapt and flourish. People with autism have impaired behavioral and thinking flexibility and experience high levels of anxiety, as change and adaptation do not come naturally. The disability inherent in autism is by definition the impaired social and occupational functioning that results from lack of adaptation. The point of the behavioral triad of restricted and repetitive interests, activities, and behaviors has received relatively little attention as compared to the other two points of the triad. METHODS: A review of the literature related to restricted and repetitive interests and activities and behaviors and autism was conducted to inform this theoretical review. FINDINGS: This paper considers the overly regulated thought and behavior inherent in autism spectrum disorders through the lens of dynamical systems, and an explanatory model is generated. CONCLUSION: The mathematical tools applied to understand dynamical systems may be a fruitful basis of further research to enable the movement from a theoretical concept of overly regulated thinking and behavior in autism to an empirically derived understanding.
Lien vers le texte intégral (Open Access ou abonnement)
4. Dalton NR, Chandler S, Turner C, Charman T, Pickles A, Simonoff E, Baird G. {{Measurement of urine indolylacroylglycine is not useful in the diagnosis or dietary management of autism}}. {Autism Res};2016 (Aug 29)
To measure urine indolylacroylglycine (IAG) excretion using the IAG:creatinine ratio in children with autism spectrum disorder (ASD) compared with two groups of age matched controls, one with special needs but without ASD (SEN) and one typically developing (TD) and in subgroups with/without current gastrointestinal problems and ASD with and without regression. IAG:creatinine ratio was measured in the urine of 279 children aged 10-14 years: 129 children with ASD (28 with and 101 without regression), 62 SEN controls and 88 TD controls. The prevalence of gastro-intestinal symptoms (GIS) was recorded. No differences were found in the urine IAG:creatinine ratio among groups ASD, TD and SEN; nor in the ASD groups with/without regression, nor in those with/without GIS. This study finds no evidence of increased urine IAG excretion in children with ASD, with or without GIS or with or without regression. Urinary IAG measurements in children with ASD offer no support for increased presence of neuroactive peptides proposed to result from increased gut permeability. We found measurement of urinary IAG to have no value in the diagnosis of autism or in the dietary management of children with ASD. Autism Res 2016,. (c) 2016 International Society for Autism Research, Wiley Periodicals, Inc.
Lien vers le texte intégral (Open Access ou abonnement)
5. Finucane B, Myers SM. {{Genetic Counseling for Autism Spectrum Disorder in an Evolving Theoretical Landscape}}. {Curr Genet Med Rep};2016;4:147-153.
PURPOSE OF REVIEW: Psychiatry is steadily moving toward a new conceptualization of brain disorders that blurs long-held diagnostic distinctions among neurodevelopmental and psychiatric conditions, including autism. Genomic discoveries are driving these changing perceptions, yet there has so far been minimal impact on traditional genetic counseling practices that continue to view autism through the lens of a dichotomous, all-or-none risk model. RECENT FINDINGS: High rates of comorbidity exist across autism spectrum disorder, schizophrenia, intellectual disability, and other brain-based disorders. Recent epidemiological studies have shown that co-occurrence of neurodevelopmental and psychiatric disorders is the rule, rather than the exception, in affected individuals and within families. Moreover, studies of chromosomal microarray analysis and whole exome sequencing have now detected many of the same pathogenic copy number and sequence-level variants across cohorts with different clinical presentations. SUMMARY: Going forward, the genetic counseling field will need to significantly adapt its approaches to pedigree interpretation, variant analysis, and patient education to more precisely describe both the chance and the nature of autism recurrence in terms of a continuum of brain dysfunction. These efforts will have implications for multiple practice areas and require philosophical changes for experienced practitioners and for the training of new genetic counselors. Resetting entrenched dichotomous notions about autism and other brain-based manifestations of genetic conditions will require a strategic educational effort on the part of the genetic counseling profession.
Lien vers le texte intégral (Open Access ou abonnement)
6. Hashimoto RI, Itahashi T, Ohta H, Yamada T, Kanai C, Nakamura M, Watanabe H, Kato N. {{Altered effects of perspective-taking on functional connectivity during self- and other-referential processing in adults with autism spectrum disorder}}. {Soc Neurosci};2016 (Aug 30):1-12.
In interactive social situations, it is often crucial to be able to take another person’s perspective when evaluating one’s own or another person’s specific trait; individuals with autism spectrum disorder (ASD) critically lack this social skill. To examine how perspective-dependent self- and other-evaluation processes modulate functional connectivity in ASD, we conducted a functional magnetic resonance imaging study in which 26 high-functioning adults with ASD and 24 typically developed (TD) controls were asked to decide whether an adjective describing a personality trait correctly described the participant himself/herself (« self ») or the participant’s mother (« other ») by taking either the first (1P) or third person (3P) perspective. We observed that functional connectivity between the left sensorimotor cortex and the left middle cingulate cortex was enhanced in TD control individuals taking the 3P perspective, this enhancement was significantly reduced in ASD, and the degree of reduction was significantly correlated with the severity of autistic traits. Furthermore, the self-reference effect on functional connectivity between the left inferior frontal cortex and frontopolar cortices was significantly enhanced in TD control individuals taking the 3P perspective, whereas such effect was reversed in ASD. These findings indicate altered effects of perspective on the functional connectivity, which may underlie the deficits in social interaction and communication observed in individuals with ASD.
Lien vers le texte intégral (Open Access ou abonnement)
7. Lafleur A, Soulieres I, Forgeot d’Arc B. {{Cognition sociale et sens de l’agentivité en autisme : de l’action a l’interaction.}}. {Sante Ment Que};2016 (Spring);41(1):163-181.
The sense of agency (SoA) refers to the ability for one to detect that she is the cause of an action (Gallagher, 2000). The SoA is linked to motor control but also to self-awareness and could play an important role in social interactions. Autism spectrum disorder (ASD) is characterized by an alteration of social interactions and communication (DSM-5; APA, 2013) and is often seen as a primary deficit of functions specific to social cognition. However, motor control is also altered in ASD. We hypothesize that motor symptoms and social impairments could both arise from the same alteration of SoA. We first introduce theoretical models of implicit and explicit SoA (Synofzik et al., 2008) and present their neurofunctional basis. Then, we assess the clinical expressions of a disrupted SoA in different neuropsychiatric disorders such as schizophrenia. In ASD, the atypical formation of internal models of action during motor acquisition (Haswell et al., 2009) could be at the source of an altered implicit SoA. A lack of fidelity of sensorimotor agency cues (Zalla et al., 2015) could also entail an alteration of explicit SoA. We discuss the main clinical expressions of ASD that may ensue from a disrupted SoA (difficulties in theory of mind and imitation, deficits in motor coordination and praxis, etc.).
Lien vers le texte intégral (Open Access ou abonnement)
8. Leppa VM, Kravitz SN, Martin CL, Andrieux J, Le Caignec C, Martin-Coignard D, DyBuncio C, Sanders SJ, Lowe JK, Cantor RM, Geschwind DH. {{Rare Inherited and De Novo CNVs Reveal Complex Contributions to ASD Risk in Multiplex Families}}. {Am J Hum Genet};2016 (Sep 1);99(3):540-554.
Rare mutations, including copy-number variants (CNVs), contribute significantly to autism spectrum disorder (ASD) risk. Although their importance has been established in families with only one affected child (simplex families), the contribution of both de novo and inherited CNVs to ASD in families with multiple affected individuals (multiplex families) is less well understood. We analyzed 1,532 families from the Autism Genetic Resource Exchange (AGRE) to assess the impact of de novo and rare CNVs on ASD risk in multiplex families. We observed a higher burden of large, rare CNVs, including inherited events, in individuals with ASD than in their unaffected siblings (odds ratio [OR] = 1.7), but the rate of de novo events was significantly lower than in simplex families. In previously characterized ASD risk loci, we identified 49 CNVs, comprising 24 inherited events, 19 de novo events, and 6 events of unknown inheritance, a significant enrichment in affected versus control individuals (OR = 3.3). In 21 of the 30 families (71%) in whom at least one affected sibling harbored an established ASD major risk CNV, including five families harboring inherited CNVs, the CNV was not shared by all affected siblings, indicating that other risk factors are contributing. We also identified a rare risk locus for ASD and language delay at chromosomal region 2q24 (implicating NR4A2) and another lower-penetrance locus involving inherited deletions and duplications of WWOX. The genetic architecture in multiplex families differs from that in simplex families and is complex, warranting more complete genetic characterization of larger multiplex ASD cohorts.
Lien vers le texte intégral (Open Access ou abonnement)
9. Liu N, Cliffer S, Pradhan AH, Lightbody A, Hall SS, Reiss AL. {{Optical-imaging-based neurofeedback to enhance therapeutic intervention in adolescents with autism: methodology and initial data}}. {Neurophotonics};2017 (Jan);4(1):011003.
Impaired facial processing may contribute to social dysfunction in certain individuals with autism spectrum disorder (ASD). Prior studies show that electroencephalogram-based and functional magnetic resonance imaging-based neurofeedback might help some individuals with ASD learn to modulate regional brain activity and thus reduce symptoms. Here, we report for the first time the feasibility of employing functional near-infrared spectroscopy (fNIRS)-based neurofeedback training in children with ASD. We developed a method to study physiological self-regulation of oxy-hemoglobin using real-time feedback. The paradigm is illustrated with initial data from four subjects who engaged in a facial-identity recognition training program during which an implicit reinforcement was given based on the participant’s brain activity and behavioral performance. Two participants had a confirmed diagnosis of ASD, and the other two were typically developing (TD). One participant with ASD and one TD participant received real-feedback (real-FB) during the training, whereas the other two received sham-feedback (sham-FB). After five training sessions, the subjects who received real-FB showed more improvement in facial recognition performance compared with those receiving sham-FB, particularly in the participant with ASD. These results suggest fNIRS-based neurofeedback could enhance therapeutic intervention in children with ASD.
Lien vers le texte intégral (Open Access ou abonnement)
10. Nuske HJ, Vivanti G, Dissanayake C. {{Others’ emotions teach, but not in autism: an eye-tracking pupillometry study}}. {Mol Autism};2016;7(1):36.
BACKGROUND: Much research has investigated deficit in emotional reactivity to others in people with autism, but scant attention has been paid to how this deficit affects their own reactions to features of their environment (objects, events, practices, etc.). The present study presents a preliminary analysis on whether calibrating one’s own emotional reactions to others’ emotional reactions about features of the world, a process we term social-emotional calibration, is disrupted in autism. METHODS: To examine this process, we used a novel eye-tracking pupillometry paradigm in which we showed 20 preschoolers with autism and 20 matched typically developing preschoolers’ videos of an actor opening a box and reacting to the occluded object inside, with fear or happiness. We expected preschoolers to come to perceive the box as containing a positive or threatening stimulus through emotionally calibrating to the actor’s emotional expressions. Children’s mean pupil diameter (indicating emotional reactivity) was measured whilst viewing an up-close, visually identical image of the box before and then after the scene, and this difference was taken as an index of social-emotional calibration and compared between groups. RESULTS: Whilst the typically developing preschoolers responded more emotionally to the box after, compared to before the scene (as indexed by an increase in pupil size), those with autism did not, suggesting their reaction to the object was not affected by the actor’s emotional expressions. The groups did not differ in looking duration to the emotional expressions; thus, the pupil dilation findings cannot be explained by differences in visual attention. More social-emotional calibration on the happy condition was associated with less severe autism symptoms. CONCLUSIONS: Through the measurement of physiological reactivity, findings suggest social-emotional calibration is diminished in children with autism, with calibration to others’ positive emotions as particularly important. This study highlights a possible mechanism by which individuals with autism develop idiosyncratic reactions to features of their environment, which is likely to impact their active and harmonious participation on social and cultural practices from infancy, throughout the lifespan. More research is needed to examine the mediators and developmental sequence of this tendency to emotionally calibrate to others’ feelings about the world.
Lien vers le texte intégral (Open Access ou abonnement)
11. Ooi YP, Weng SJ, Kossowsky J, Gerger H, Sung M. {{Oxytocin and Autism Spectrum Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials}}. {Pharmacopsychiatry};2016 (Aug 30)
Aim: Oxytocin presents an exciting potential to target the core symptoms of autism spectrum disorder (ASD) pharmacologically in an easily administered, cost-effective form with possibly minimal adverse effects. But, there are still major gaps in this area of research. This paper reviewed randomized controlled trials (RCTs) examining the effects of oxytocin administration on social cognition and restricted, repetitive behaviors in individuals with an ASD. Method: Electronic literature searches were conducted from PsycINFO, PubMed, Web of Knowledge, and EMBASE for RCTs published through June 2015. Results: 12 RCTs were included in this review. 7 out of the 11 studies that examined social cognition reported improvements. Additionally, one out of the 4 studies on restricted, repetitive behaviors, reported improvements following oxytocin administration. However, results from our meta-analyses suggest that oxytocin has no significant effect on these 2 domains. Conclusion: Previous evidence revealed mixed findings about the effects of oxytocin on ASD. Given the limited number of RCTs, our summary of findings on the effectiveness of oxytocin on ASD should still be considered tentative.
Lien vers le texte intégral (Open Access ou abonnement)
12. Puig-Alcaraz C, Fuentes-Albero M, Cauli O. {{Relationship between adipic acid concentration and the core symptoms of autism spectrum disorders}}. {Psychiatry Res};2016 (Aug 30);242:39-45.
Dicarboxylic acids are an important source of information about metabolism and potential physiopathological alterations in children with autism spectrum disorders (ASDs). We measured the concentration between dicarboxylic adipic and suberic acids in children with an ASD and typically-developing (TD) children and analyzed any relationships between the severity of the core symptoms of ASDs and other clinical features (drugs, supplements, drugs, or diet). The core symptoms of autism were evaluated using the DSM-IV criteria, and adipic acid and suberic acid were measured in urine samples. Overall, no increase in the concentration of adipic acid in children with ASDs compared to TD children, however when considering vitamin B supplementation in ASD there were significantly increased level of urinary adipic acid in children with an ASD not taking vitamin B supplementation compared to supplemented children or to TD children. No significant difference were observed in suberic acid. Interestingly, the increase in adipic acid concentration was significantly and indirectly correlated with the severity of the deficit in socialization and communication skills in children with an ASD. Therefore, therapeutic treatments aimed at decreasing adipic acid concentration might not be beneficial for treating the core symptoms of ASDs.
Lien vers le texte intégral (Open Access ou abonnement)
13. Westmark CJ, Sokol DK, Maloney B, Lahiri DK. {{Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism}}. {Mol Psychiatry};2016 (Aug 30)
Fragile X syndrome (FXS) is the most common form of inherited intellectual disability and is associated with up to 5% of autism cases. Several promising drugs are in preclinical testing for FXS; however, bench-to-bedside plans for the clinic are severely limited due to lack of validated biomarkers and outcome measures. Published work from our laboratories has demonstrated altered levels of amyloid-beta (Abeta) precursor protein (APP) and its metabolites in FXS and idiopathic autism. Westmark and colleagues have focused on beta-secretase (amyloidogenic) processing and the accumulation of Abeta peptides in adult FXS models, whereas Lahiri and Sokol have studied alpha-secretase (non-amyloidogenic or anabolic) processing and altered levels of sAPPalpha and Abeta in pediatric autism and FXS. Thus, our groups have hypothesized a pivotal role for these Alzheimer’s disease (AD)-related proteins in the neurodevelopmental disorders of FXS and autism. In this review, we discuss the contribution of APP metabolites to FXS and autism pathogenesis as well as the potential use of these metabolites as blood-based biomarkers and therapeutic targets. Our future focus is to identify key underlying mechanisms through which APP metabolites contribute to FXS and autism condition-to-disease pathology. Positive outcomes will support utilizing APP metabolites as blood-based biomarkers in clinical trials as well as testing drugs that modulate APP processing as potential disease therapeutics. Our studies to understand the role of APP metabolites in developmental conditions such as FXS and autism are a quantum leap for the neuroscience field, which has traditionally restricted any role of APP to AD and aging.Molecular Psychiatry advance online publication, 30 August 2016; doi:10.1038/mp.2016.134.
Lien vers le texte intégral (Open Access ou abonnement)
14. Wu HF, Chen PS, Chen YJ, Lee CW, Chen IT, Lin HC. {{Alleviation of N-Methyl-D-Aspartate Receptor-Dependent Long-Term Depression via Regulation of the Glycogen Synthase Kinase-3beta Pathway in the Amygdala of a Valproic Acid-Induced Animal Model of Autism}}. {Mol Neurobiol};2016 (Aug 30)
The amygdala plays crucial roles in socio-emotional behavior and cognition, both of which are abnormal in autism spectrum disorder (ASD). Valproic acid (VPA)-exposed rat offspring have demonstrated ASD phenotypes and amygdala excitatory/inhibitory imbalance. However, the role of glutamatergic synapses in this imbalance remains unclear. In this study, we used a VPA-induced ASD-like model to assess glutamatergic synapse-dependent long-term depression (LTD) and depotentiation (DPT) in the amygdala. We first confirmed that the VPA-exposed offspring exhibited sociability deficits, anxiety, depression-like behavior, and abnormal nociception thresholds. Then, electrophysiological examination showed a significantly decreased paired-pulse ratio in the amygdala. In addition, both NMDA-dependent LTD and DPT were absent from the amygdala. Furthermore, we found that the levels of glycogen synthase kinase3beta (GSK-3beta) phosphorylation and beta-catenin were significantly higher in the amygdala of the experimental animals than in the controls. Local infusion of phosphatidylinositol 3-kinase (PI3K) inhibitor wortmannin into the amygdala reversed the increased phosphorylation level and impaired social behavior. Taken together, the results suggested that NMDA receptor-related synaptic plasticity is dysfunctional in VPA-exposed offspring. In addition, GSK-3beta in the amygdala is critical for synaptic plasticity at the glutamatergic synapses and is related to social behavior. Its role in the underlying mechanism of ASD merits further investigation.
Lien vers le texte intégral (Open Access ou abonnement)
15. Wu YE, Parikshak NN, Belgard TG, Geschwind DH. {{Genome-wide, integrative analysis implicates microRNA dysregulation in autism spectrum disorder}}. {Nat Neurosci};2016 (Aug 29)
Genetic variants conferring risk for autism spectrum disorder (ASD) have been identified, but the role of post-transcriptional mechanisms in ASD is not well understood. We performed genome-wide microRNA (miRNA) expression profiling in post-mortem brains from individuals with ASD and controls and identified miRNAs and co-regulated modules that were perturbed in ASD. Putative targets of these ASD-affected miRNAs were enriched for genes that have been implicated in ASD risk. We confirmed regulatory relationships between several miRNAs and their putative target mRNAs in primary human neural progenitors. These include hsa-miR-21-3p, a miRNA of unknown CNS function that is upregulated in ASD and that targets neuronal genes downregulated in ASD, and hsa_can_1002-m, a previously unknown, primate-specific miRNA that is downregulated in ASD and that regulates the epidermal growth factor receptor and fibroblast growth factor receptor signaling pathways involved in neural development and immune function. Our findings support a role for miRNA dysregulation in ASD pathophysiology and provide a rich data set and framework for future analyses of miRNAs in neuropsychiatric diseases.
